HD-OPM Archive
Hashtags

#visceralfat

75 posts

Roy Taylor trial: clearing liver and pancreas fat via 8-week low-calorie diet reversed T2D

Sep 01, 2024 · Louis Nervegna ♥ 24 · 💬 22 ↩ 21 Insulin resistance & diabetes

Louis summarizes Roy Taylor's randomized trial in which an 8-week very low calorie liquid diet cleared fat from the liver and pancreas, restoring insulin sensitivity and beta cell function and putting diabetes into remission. Average weight loss needed was about 15 kg (33 lb), followed by a Mediterranean-style maintenance diet. Some patients had a full curative response with pancreas regeneration seen on imaging.

Liver fat is the main driver of insulin resistance, and visceral fat is a visible marker

Sep 24, 2024 · Louis Nervegna ♥ 21 · 💬 25 Insulin resistance & diabetes

Louis reposts a Harvard diabetologist's explanation that in most people fat stored in the liver is the biggest cause of insulin resistance. Losing liver fat by any means dramatically improves it, and weight loss removes liver fat first. Refined starch and sugar-sweetened drinks raise the odds, though excess calories alone can do it. Visible abdominal visceral fat is a simple proxy.

Big glucose spikes from oats signal insulin resistance; only losing visceral fat cures it

Mar 01, 2025 · Louis Nervegna ♥ 23 · 💬 8 Insulin resistance & diabetes

Louis argues that large glucose spikes from low-to-moderate GI carbs suggest prediabetes or diabetes, and that cutting carbs only masks the problem unless enough weight is lost to clear liver and pancreas fat. He adds that visceral fat can hide in people with normal BMI, that Asians develop insulin resistance at lower visceral fat levels, and summarizes Roy Taylor's very-low-calorie diet trials.

Sumo wrestlers stay metabolically healthy because heavy exercise shifts fat under the skin

Mar 09, 2025 · Louis Nervegna ♥ 21 · 💬 9 Weight, visceral & liver fat

Louis explains why sumo wrestlers, despite huge calorie and refined-carbohydrate intake, store little fat in the liver and pancreas and little visceral fat. He attributes this to up to 7 hours of daily exercise, which releases adiponectin and steers fat storage to subcutaneous tissue, a reason exercise protects against metabolic syndrome and diabetes.

Normal fruit intake does not raise liver or visceral fat

Dec 03, 2025 · Louis Nervegna ♥ 16 · 💬 4 Carbs, fiber, sugar & whole grains

Louis quotes a post arguing that 500 g/day of added fruit for 2 months did not raise MRI liver fat despite nearly tripled fructose intake, and that fructose harms appear in extreme overfeeding studies with fructose-sweetened drinks. In calorie-matched trials, fructose replacing other carbs did not raise liver fat or ALT.

Tirzepatide cut 3-year diabetes incidence to 1.3% vs 13.3% in SURMOUNT-1

Mar 06, 2025 · Louis Nervegna ♥ 12 · 💬 5 GLP-1 drugs (semaglutide, tirzepatide)

Louis shares Luigi Fontana's post on the 3-year SURMOUNT-1 results and adds that weight loss clears fat from liver and pancreas, the main cause of insulin resistance and beta-cell dysfunction, so any diet producing major weight loss can do the same. The shared post also warns about muscle/bone loss and nutrient deficiencies without exercise and good nutrition.

MESA: high Lp(a) raised ASCVD risk 2.34-fold only in people with large waist-to-hip ratio

Oct 18, 2025 · Louis Nervegna ♥ 10 · 💬 5 ↩ 4 Lp(a)

Louis summarizes a MESA cohort analysis in Progress in Cardiovascular Diseases showing waist-to-hip ratio (a visceral-fat and liver-fat proxy) modifies the ASCVD risk of Lp(a), while BMI did not. Lp(a) of 50 mg/dL or more with high WHR carried the excess risk, which mostly vanished when WHR was low. He stresses this is a prospective cohort, so it cannot prove causality, but suggests losing visceral fat is important with high Lp(a).

Waist size predicted future disability better than 9 other aging and fitness measures

Nov 02, 2026 · Louis Nervegna ♥ 6 · 💬 5 Weight, visceral & liver fat

Whitehall II data on 4,593 UK adults (average age 65) followed for about 11 years compared 10 standard measures, including walking speed, chair rises, balance, grip strength, lung function and BMI. Waist size predicted disability, and severe disability, best, and adding other tests improved prediction only slightly. Waist reflects visceral fat, which drives inflammation, insulin resistance and liver fat.

Visceral fat had the strongest inflammatory protein signature of any trait in VITAL/COSMOS

Nov 05, 2026 · Louis Nervegna ♥ 10 · 💬 2 Weight, visceral & liver fat

Louis shares a cross-sectional proteomics analysis of 896 adults from VITAL and COSMOS. Visceral fat measured by DXA was associated with 221 circulating proteins, more than blood pressure, HDL, triglycerides or insulin resistance. It cannot prove causation, but suggests visceral fat is a meaningful target for reducing chronic inflammation.

Semaglutide improved MASH inflammation and fibrosis in the Phase 3 ESSENCE trial

Jun 08, 2025 · Louis Nervegna ♥ 5 · 💬 4 GLP-1 drugs (semaglutide, tirzepatide)

The post argues that liver and pancreas fat drive diabetes, insulin resistance and metabolic syndrome, and that fat leaves the liver early on a diet, which is why GLP-1 drugs work well in fatty liver disease. The shared summary describes the ESSENCE trial of weekly semaglutide 2.4 mg in biopsy-proven MASH with fibrosis stage 2-3 and lists open questions such as cirrhosis and durability.

Diet alone restored pancreas and beta-cell function in a Roy Taylor trial patient

Dec 19, 2025 · Louis Nervegna ♥ 12 Insulin resistance & diabetes

Louis re-shares his post on a patient in Roy Taylor's randomized trial whose advanced type 2 diabetes fully resolved after 2 years, with the pancreas imaging almost back to normal. The intervention was 8 weeks of an 800-calorie meal-replacement diet followed by a normal-calorie Mediterranean diet for maintenance. He argues the liver and pancreas were cleared of fat and that some people get a full curative response, though not everyone.

Why insulin resistance lowers HDL, and why improving insulin sensitivity beats chasing HDL

Mar 21, 2024 · Louis Nervegna ♥ 5 ↩ 10 LDL, ApoB & lipid panel

Louis lists six mechanisms by which insulin resistance lowers HDL: impaired HDL maturation (lower LCAT), reduced apoA-I production, faster HDL catabolism (hepatic lipase, CETP), altered HDL composition and function, higher triglycerides making small dense HDL, and inflammation and oxidative stress. He concludes the best way to raise HDL is improving insulin sensitivity (lose visceral fat, exercise, cut refined starch and sugar), since insulin resistance is causal in heart disease while large RCTs suggest HDL itself is probably not.

Green Mediterranean diet cut visceral fat about 14% in an 18-month randomized trial

Oct 30, 2026 · Louis Nervegna ♥ 3 Mediterranean, DASH, MIND & plant-forward diets

A shared summary of an 18-month RCT comparing a healthy diet, a Mediterranean diet and a Green Mediterranean diet enriched with green tea and Wolffia globosa (mankai duckweed). The Green Mediterranean diet reduced visceral fat by about 14%, the largest effect of the three arms. Visceral fat drives inflammation and metabolic dysfunction.

Excess body fat can cut testosterone by up to half a reference range; fat loss restores it

Mar 25, 2026 · Louis Nervegna ♥ 3 Hormones, women's & men's health

Louis posts that overweight and obesity can lower testosterone by as much as half a reference range (about 350 ng/dL) and that losing visceral fat often returns levels to normal. The shared FoundMyFitness post explains that extra fat raises aromatization of testosterone to estrogen, which signals the brain to reduce testosterone production.